Figure 1. Effects of Mimosa caesalpiniifolia pre-formulation on the clinical activity index. A) Total clinical score activity index: ^a basal control vs 5% untreated dextran sulphate sodium (DSS) induced colitis - p=0.0003; ^b 5% untreated DSS-induced colitis (DSS) vs Mimosa caesalpiniifolia pre formulation control and 5% DSS-induced colitis treated with Mimosa caesalpiniifolia preformulation (DSSMC) - p=0.0003; B) Body weight. There were non-significant diferences between groups according to Tukey's test (eight rats per group).

BC: basal control; DSS: dextran sulphate sodium; MCC: Mimosa caesalpiniifolia pre formulation control; DSSMC: DSS-induced colitis treated with Mimosa caesalpiniifolia pre-formulation